Immunome Inc. IMNM
$18.11
▲ +0.11% 24H
About
Immunome Inc. is a biotechnology company specializing in highly innovative research and development within the life sciences sector. The primary focus of the company is to advance immunotherapy-based cancer treatments through its proprietary discovery engine that harnesses the immune system's natural capabilities. Immu…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees206
TickerIMNM
Statistics
Market Cap$2.05B
Revenue (TTM)$6.9M
Net Income-$212.4M
Net Margin-3060.0%
EPS$-2.43
P/E-7.57
P/S512.24
P/B3.49
EV/EBITDA-6.53
ROE-50.1%
Dividend Yield—
Price$18.11
Data: Twelve Data · Revenue = mcap / P/S